NCT05518110 2026-04-13
PaTcH
Cancer Trials Ireland
Phase 2 Terminated
Clinical Trials
34 trialsNCT06807437 2026-03-31
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
SWOG Cancer Research Network
Phase 3 Recruiting
NCT06998940 2026-03-27
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
SWOG Cancer Research Network
Phase 3 Recruiting
NCT04233866 2026-03-23
Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread
Eastern Cooperative Oncology Group
Phase 2 Active not recruiting
NCT04239573 2026-03-23
Comparing Two Methods to Follow Patients With Pancreatic Cysts
Eastern Cooperative Oncology Group
Phase NA Active not recruiting
NCT02598349 2025-09-09
Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas
Proton Collaborative Group
Phase 2 Recruiting
NCT06149546 2025-07-08
FEED
Cancer Trials Ireland
Phase NA Recruiting
NCT06094140 2024-12-03
NEO-IMPACT
Australasian Gastro-Intestinal Trials Group
Phase 2 Active not recruiting
NCT05042128 2024-10-22
ASCEND
Australasian Gastro-Intestinal Trials Group
Phase 2 Active not recruiting
NCT04498767 2024-08-26
OligoRARE
European Organisation for Research and Treatment of Cancer - EORTC
Phase NA Recruiting
NCT06212700 2024-04-25
PRIORITY-CONNECT 2 Pilot Trial
Surgical Outcomes Research Centre (SOuRCe)
Phase NA Recruiting
NCT00265876 2023-08-04
AZD0530 and Gemcitabine in Locally Advanced/Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery
Canadian Cancer Trials Group
Phase 1/2 Completed
NCT00042939 2023-07-06
Irinotecan and Docetaxel With or Without Cetuximab in Treating Patients With Metastatic Pancreatic Cancer
Eastern Cooperative Oncology Group
Phase 2 Completed
NCT00057876 2023-07-05
Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer
Eastern Cooperative Oncology Group
Phase 3 Completed
NCT00003810 2023-06-15
Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas
Eastern Cooperative Oncology Group
Phase 2 Completed
NCT00049348 2023-06-15
Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer
Eastern Cooperative Oncology Group
Phase 2 Completed
NCT04089150 2021-10-22
MASTERPLAN
Australasian Gastro-Intestinal Trials Group
Phase 2 Unknown
NCT00016380 2020-04-03
Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen
Canadian Cancer Trials Group
Phase 3 Completed
NCT00026338 2020-04-02
Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer
Canadian Cancer Trials Group
Phase 3 Completed
NCT01921751 2018-07-13
High or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery
Radiation Therapy Oncology Group
Phase 2 Terminated
NCT00005832 2015-11-17
S9924 R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
SWOG Cancer Research Network
Phase 2 Completed
NCT00075686 2015-11-17
S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
SWOG Cancer Research Network
Phase 3 Completed
NCT01298401 2015-11-17
Ganitumab and Gemcitabine Hydrochloride Followed by Radiation Therapy, Ganitumab, Capecitabine, and Maintenance Therapy in Treating Patients With Locally Advanced Cancer of the Pancreas
Radiation Therapy Oncology Group
Phase 1 Completed
NCT01419002 2015-07-29
Net-Pac
CHIR-Net
Phase 3 Terminated
NCT00962312 2014-12-31
Lapatinib Ditosylate and Capecitabine in Treating Patients With Metastatic Pancreatic Cancer
Cancer Trials Ireland
Phase 2 Completed
NCT00003216 2013-11-19
Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas
Radiation Therapy Oncology Group
Phase 3 Completed
NCT00003591 2013-11-13
Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer
Radiation Therapy Oncology Group
Phase 2 Completed
NCT01017822 2013-06-24
Conatumumab, Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer
Radiation Therapy Oncology Group
Phase 1/2 Withdrawn
NCT00003018 2013-01-03
S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer
SWOG Cancer Research Network
Phase 2 Completed
NCT00004884 2012-09-24
Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed
NCT00005053 2012-09-24
Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed
NCT00064207 2012-09-24
Gemcitabine and Radiation Therapy Compared With Gemcitabine Alone in Treating Patients Who Have Undergone Surgery for Pancreatic Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2/3 Completed
NCT00003029 2012-07-02
Fluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Completed
NCT00813696 2008-12-23
GIP-1
Istituti Tumori Giovanni Paolo II
Phase 3 Unknown